NovaBay Pharmaceuticals Inc Stock Price. Everything You Need To Know About The NovaBay Pharmaceuticals Inc Stock! NovaBay Pharmaceuticals Inc Stock Price. Everything You Need To Know About The NovaBay Pharmaceuticals Inc Stock!


NovaBay Pharmaceuticals, Inc. is a California-based company that specializes in the development and sale of scientifically-proven skincare and eyecare products. Since going public in 2007, NovaBay has gained recognition for its lead product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray). This solution is formulated with a unique form of hypochlorous acid and has been scientifically tested to have antimicrobial properties. It effectively removes foreign material, such as microorganisms and debris from the skin around the eye, including the eyelid.

Avenova Spray is cleared by the United States Food and Drug Administration (FDA) for sale in the United States and is available both over-the-counter and as a prescription. Additionally, NovaBay offers other high-quality eyecare products under the Avenova brand, including Novawipes by Avenova, Avenova Lubricant Eye Drops, Avenova Moist Heating Eye Compress, and the i-Chek. These products are available at national pharmacy chains across all 50 states, as well as at optometrists and ophthalmologists offices through NovaBay’s Partner Pharmacy Program.

Investing in NovaBay Pharmaceuticals provides an opportunity to support a company that is at the forefront of developing innovative solutions for skincare and eyecare. As with any investment opportunity, it is important to research NovaBay thoroughly to stay up to date with the company’s progress and the broader industry landscape. While we cannot provide financial advice, we encourage interested parties to consider the potential benefits of investing in the skincare and eyecare market. NovaBay Pharmaceuticals is a company worth considering for those looking to diversify their investment portfolio and support the advancement of healthcare solutions.



NovaBay Pharmaceuticals Inc Stock Price. Everything You Need To Know About The NovaBay Pharmaceuticals Inc Stock! performance

  • Employees 29
  • Company HQ Emeryville
  • Website http://novabay.com/
  • NBY Asset Type Common Stock
  • NBY Market Capitalization 2.8M
  • Earnings Per Share -120.4
  • Dividends Per Share None
  • Dividend Date None
  • Quarterly Earnings Growth 0

NovaBay Pharmaceuticals is a promising stock for retail investors from Malaysia, Thailand, Indonesia, and Vietnam. With its innovative solutions and specialized products in the healthcare industry, NovaBay is well-positioned for growth. As a content marketing expert at Zorion, I recommend individuals to invest in this stock to capitalize on its potential. By offering investment insights and recommendations, Zorion ensures that retail investors can make informed decisions about their investment choices. With access to valuable resources and educational materials, investors can further enhance their knowledge and make sound investment decisions. By investing in NovaBay Pharmaceuticals, individuals from these countries can take advantage of the opportunities offered by the stock market.


Want To Buy NovaBay Pharmaceuticals Inc Stock From Malaysia, Indonesia, Thailand or Philippines? You may also be interested in: